Corbus Pharmaceuticals Holdings Inc

-0.03 (-3.61%)
Earnings Announcements

Corbus Pharma Reports Q3 Loss Per Share Of $0.02

Published: 11/12/2021 13:20 GMT
Corbus Pharmaceuticals Holdings Inc (CRBP) - Corbus Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Updates.
Q3 Loss per Share $0.02.
Corbus Pharmaceuticals Holdings - Cash and Investments on Hand Sufficient to Support Execution of Research, Clinical & Operational Goals Into Q1 2024.
Q3 Earnings per Share View $-0.12 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.35 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.